Marc Thill Selected Research

Marc Thill Research Topics

Disease

72	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2009
25	Neoplasms (Cancer) 01/2024 - 09/2009
7	Pathologic Complete Response 11/2023 - 01/2018
6	Neoplasm Metastasis (Metastasis) 11/2022 - 08/2011
4	Triple Negative Breast Neoplasms 09/2023 - 04/2021
4	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2022 - 12/2011
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2017 - 08/2011
4	Carcinogenesis 11/2017 - 12/2011
4	Ovarian Neoplasms (Ovarian Cancer) 02/2015 - 09/2009
4	Carcinoma (Carcinomatosis) 02/2015 - 07/2010
3	Inflammation (Inflammations) 01/2018 - 07/2010
3	Margins of Excision 02/2014 - 12/2011
2	Wounds and Injuries (Trauma) 04/2021 - 06/2011
2	Vulvar Neoplasms (Vulvar Cancer) 01/2012 - 01/2012
1	Residual Neoplasm 09/2022
1	Brain Neoplasms (Brain Tumor) 06/2022
1	Brain Diseases (Brain Disorder) 09/2020
1	Male Breast Neoplasms (Male Breast Cancer) 01/2020
1	Diarrhea 01/2018
1	Neutropenia 01/2018
1	Lymphatic Metastasis 11/2017

Drug/Important Bio-Agent (IBA)

13	Hormones (Hormone)IBA 12/2023 - 02/2015
11	Vitamin D FDA LinkGeneric 01/2018 - 09/2009
9	Calcitriol (Calcijex)FDA LinkGeneric 01/2018 - 09/2009
8	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2016 - 09/2009
7	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2019
5	Immune Checkpoint InhibitorsIBA 09/2023 - 04/2020
5	Trastuzumab (Herceptin)FDA Link 11/2022 - 03/2015
5	Dinoprostone (PGE2)FDA Link 01/2018 - 09/2009
5	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2012 - 09/2009
5	EnzymesIBA 11/2010 - 09/2009
4	Phenobarbital (Luminal)FDA Link 11/2023 - 03/2018
4	130-nm albumin-bound paclitaxelIBA 11/2023 - 04/2012
4	human ERBB2 proteinIBA 01/2020 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2015
4	Messenger RNA (mRNA)IBA 01/2018 - 01/2014
4	15-hydroxyprostaglandin dehydrogenaseIBA 01/2012 - 09/2009
3	abemaciclibIBA 06/2023 - 01/2018
3	sacituzumab govitecanIBA 03/2023 - 04/2021
3	Immunoconjugates (Immunoconjugate)IBA 03/2023 - 04/2021
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2022 - 04/2020
3	Cyclin-Dependent Kinase 4IBA 05/2021 - 01/2018
3	Celecoxib (Celebrex)FDA Link 01/2018 - 02/2015
3	1,25-dihydroxyvitamin DIBA 01/2012 - 05/2010
3	ProstaglandinsIBA 12/2011 - 05/2010
2	Epidermal Growth Factor (EGF)IBA 12/2023 - 03/2019
2	ribociclibIBA 12/2023 - 01/2018
2	Denosumab FDA Link 11/2023 - 01/2022
2	olaparibIBA 06/2023 - 03/2023
2	pembrolizumabIBA 03/2023 - 09/2022
2	Aromatase InhibitorsIBA 11/2022 - 04/2015
2	palbociclibIBA 11/2022 - 01/2018
2	pertuzumabIBA 11/2022 - 06/2021
2	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2018
2	trastuzumab deruxtecanIBA 09/2022 - 06/2022
2	AlpelisibIBA 06/2022 - 04/2021
2	Taxoids (Taxanes)IBA 04/2020 - 04/2012
2	Monoclonal AntibodiesIBA 03/2019 - 03/2015
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018 - 02/2015
2	hydroxide ionIBA 01/2012 - 05/2010
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2011 - 08/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011 - 08/2011
2	EndostatinsIBA 08/2011 - 08/2011
2	Calcifediol (Calcidiol)FDA Link 11/2010 - 07/2010
1	2- (N- phenethyl- N- propyl)amino- 5- hydroxytetralinIBA 01/2024
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 11/2023
1	Granzymes (Granzyme)IBA 09/2023
1	atezolizumabIBA 03/2023
1	Local AnestheticsIBA 03/2023
1	Fulvestrant (Faslodex)FDA Link 11/2022
1	tucatinibIBA 06/2022
1	talazoparibIBA 02/2022
1	giredestrantIBA 02/2022
1	neratinibIBA 06/2021
1	Capecitabine (Xeloda)FDA Link 06/2021
1	Tamoxifen FDA LinkGeneric 01/2020
1	Colloids (Colloid)IBA 10/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	eribulin FDA Link 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2018
1	Albumin-Bound Paclitaxel FDA Link 03/2018
1	AnthracyclinesIBA 03/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018
1	Claudin-1IBA 11/2017
1	Tight Junction ProteinsIBA 11/2017
1	N,N'-bis(4-azidobenzoyl)cystineIBA 02/2016
1	Zoledronic Acid (Zometa)FDA Link 03/2015
1	Infliximab (Remicade)FDA Link 03/2015

Therapy/Procedure

38	Therapeutics 01/2024 - 09/2009
15	Neoadjuvant Therapy 12/2023 - 01/2018
7	Drug Therapy (Chemotherapy) 01/2024 - 08/2011
6	Segmental Mastectomy (Lumpectomy) 03/2022 - 12/2011
3	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 10/2019
2	Radiotherapy 06/2023 - 10/2021
2	Operative Surgical Procedures 10/2021 - 04/2014
1	Immunotherapy 09/2023
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 04/2021
1	Mammaplasty (Breast Reconstruction) 01/2020
1	Mastectomy (Mammectomy) 01/2020
1	Drug Tapering 01/2018